MidEuropa Completes Acquisition of Controlling Stake in FAMAR

MidEuropa, the leading private equity investor with deep roots in Central Europe, announces today that it has completed the acquisition of a controlling stake in FAMAR, a well-established pharmaceutical contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners. The current shareholders are reinvesting alongside MidEuropa and the Company’s management team.

FAMAR is a trusted partner to a diversified blue-chip client base of pharmaceutical companies operating in more than 80 international markets. The Company provides a full-service offering across the CDMO value-chain, with broad capabilities across multiple dosage forms including sterile, solids, semi-solids, and R&D services. FAMAR employs c.1,900 people working across a network of six manufacturing sites located across southern Europe with two complementary R&D centres.